Nanalysis Scientific Corp.
NSCIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9 | $10 | $11 | $12 |
| % Growth | -3% | -9.6% | -13.8% | – |
| Cost of Goods Sold | $7 | $7 | $8 | $8 |
| Gross Profit | $2 | $2 | $3 | $4 |
| % Margin | 21.9% | 24.3% | 25.6% | 34.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $3 | $2 | $2 |
| SG&A Expenses | $2 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $1 |
| Other Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Expenses | $3 | $4 | $4 | $4 |
| Operating Income | -$1 | -$2 | -$1 | $0 |
| % Margin | -12.6% | -19.2% | -10.1% | 2.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$8 |
| Pre-Tax Income | -$1 | -$2 | -$1 | -$7 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | -$2 | -$2 | -$1 | -$7 |
| % Margin | -16.2% | -22.2% | -12.3% | -60.6% |
| EPS | -0.01 | -0.019 | -0.01 | -0.066 |
| % Growth | 46.5% | -87% | 84.8% | – |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.066 |
| Weighted Avg Shares Out | 115 | 114 | 113 | 113 |
| Weighted Avg Shares Out Dil | 115 | 114 | 113 | 113 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$0 | -$1 | -$0 | -$6 |
| % Margin | -3.8% | -8.2% | -0% | -49.1% |